Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

All Cancer Sites (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, Ages <50

Sorted by Count
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 105.2 (105.0, 105.5) N/A 202,435 stable stable trend 0.1 (-0.1, 0.3)
California 7 93.4 (92.9, 94.0) 46 (44, 48) 23,789 rising rising trend 0.4 (0.3, 0.5)
Texas 7 95.8 (95.2, 96.5) 43 (40, 45) 17,901 stable stable trend 0.1 (0.0, 0.3)
New York 7 116.0 (115.2, 116.9) 3 (3, 5) 14,019 rising rising trend 0.4 (0.2, 0.6)
Florida 6 110.7 (109.9, 111.5) 14 (11, 20) 13,725 falling falling trend -1.5 (-2.2, -0.6)
Illinois 7 106.0 (105.0, 107.1) 23 (18, 31) 8,438 stable stable trend 0.4 (-0.6, 0.6)
Pennsylvania 6 113.3 (112.3, 114.4) 10 (5, 13) 8,401 falling falling trend -1.2 (-2.0, -0.3)
Ohio 6 112.4 (111.3, 113.6) 11 (6, 16) 7,678 rising rising trend 0.8 (0.5, 1.1)
Georgia 7 104.9 (103.8, 106.0) 30 (21, 35) 7,123 stable stable trend 0.3 (-0.4, 0.5)
North Carolina 6 107.1 (106.0, 108.3) 27 (19, 33) 6,816 stable stable trend -0.1 (-0.5, 0.1)
New Jersey 7 111.8 (110.6, 113.1) 9 (4, 14) 6,240 rising rising trend 0.4 (0.2, 0.5)
Michigan 6 105.8 (104.6, 107.0) 31 (22, 36) 6,128 stable stable trend 0.0 (-0.3, 0.2)
Virginia 6 96.3 (95.1, 97.5) 44 (41, 47) 5,084 stable stable trend -0.3 (-2.2, 0.1)
Washington 5 100.8 (99.5, 102.1) 39 (36, 42) 4,733 stable stable trend -0.1 (-0.3, 0.2)
Massachusetts 7 103.0 (101.6, 104.4) 35 (27, 38) 4,357 falling falling trend -1.0 (-1.5, -0.6)
Tennessee 6 105.5 (104.1, 107.0) 33 (23, 37) 4,333 falling falling trend -1.8 (-2.8, -0.6)
Maryland 6 105.7 (104.2, 107.2) 32 (21, 37) 3,930 stable stable trend 0.3 (-1.3, 1.5)
Arizona 6 92.2 (90.9, 93.5) 49 (46, 49) 3,905 stable stable trend 0.5 (0.0, 1.4)
Missouri 6 106.6 (105.1, 108.2) 29 (19, 35) 3,803 stable stable trend 0.2 (-1.9, 0.9)
Minnesota 6 114.2 (112.5, 115.8) 6 (4, 13) 3,801 rising rising trend 1.1 (0.8, 1.4)
Wisconsin 6 107.5 (105.9, 109.1) 24 (16, 33) 3,625 stable stable trend 0.3 (-0.2, 0.6)
Colorado 6 94.4 (93.0, 95.8) 47 (44, 49) 3,445 stable stable trend 0.2 (-0.1, 0.5)
Kentucky 7 122.7 (120.8, 124.6) 1 (1, 2) 3,328 rising rising trend 0.9 (0.6, 1.1)
Alabama 6 109.2 (107.5, 110.9) 18 (12, 27) 3,163 rising rising trend 0.6 (0.3, 0.9)
Louisiana 7 109.7 (107.9, 111.4) 13 (6, 22) 3,080 rising rising trend 0.9 (0.6, 1.1)
South Carolina 6 101.5 (99.9, 103.2) 38 (35, 42) 3,026 falling falling trend -0.9 (-1.9, -0.2)
Oregon 6 98.4 (96.7, 100.2) 42 (38, 45) 2,538 stable stable trend 0.2 (-0.2, 0.7)
Oklahoma 6 104.0 (102.1, 105.9) 36 (26, 39) 2,418 stable stable trend 0.4 (-0.1, 0.9)
Connecticut 7 107.9 (105.9, 109.9) 17 (11, 29) 2,319 falling falling trend -1.0 (-1.9, -0.4)
Utah 7 105.3 (103.3, 107.3) 28 (16, 36) 2,130 stable stable trend 0.6 (-0.6, 1.2)
Iowa 7 114.2 (112.0, 116.4) 4 (3, 11) 2,095 rising rising trend 1.1 (0.9, 1.3)
Arkansas 6 109.1 (107.0, 111.4) 20 (11, 32) 1,925 stable stable trend -0.3 (-2.0, 0.8)
Puerto Rico 6 107.4 (105.2, 109.6) N/A 1,865 stable stable trend 0.1 (-0.6, 0.7)
Kansas 6 110.3 (108.0, 112.6) 16 (7, 27) 1,861 stable stable trend 0.2 (-0.5, 0.5)
Mississippi 6 104.9 (102.8, 107.1) 34 (22, 39) 1,840 stable stable trend -0.1 (-1.5, 0.3)
West Virginia 6 124.3 (121.3, 127.4) 2 (1, 2) 1,302 stable stable trend 0.7 (-1.0, 1.0)
Nebraska 6 114.0 (111.2, 116.8) 7 (3, 18) 1,277 stable stable trend 1.9 (-0.2, 4.0)
New Mexico 7 92.3 (89.9, 94.7) 48 (42, 49) 1,132 rising rising trend 0.5 (0.3, 0.8)
Idaho 7 100.9 (98.2, 103.6) 37 (28, 42) 1,060 rising rising trend 0.5 (0.1, 0.8)
Hawaii 7 106.8 (103.7, 110.0) 21 (9, 36) 917 rising rising trend 0.7 (0.5, 1.0)
New Hampshire 6 110.6 (107.3, 114.0) 15 (5, 32) 867 stable stable trend 0.0 (-0.4, 0.4)
Maine 6 113.6 (110.2, 117.1) 8 (3, 21) 861 rising rising trend 0.3 (0.1, 0.5)
Rhode Island 6 107.5 (103.9, 111.3) 25 (9, 38) 666 falling falling trend -0.8 (-3.9, -0.2)
Montana 6 109.4 (105.6, 113.2) 19 (6, 36) 649 rising rising trend 0.8 (0.3, 1.5)
Delaware 6 111.2 (107.3, 115.3) 12 (4, 33) 610 stable stable trend -0.3 (-3.8, 0.4)
South Dakota 6 107.8 (103.6, 112.0) 22 (6, 38) 523 rising rising trend 0.9 (0.5, 1.2)
North Dakota 6 107.3 (102.9, 111.9) 26 (8, 39) 457 rising rising trend 1.0 (0.4, 1.7)
District of Columbia 6 95.6 (91.5, 99.8) 45 (38, 49) 451 falling falling trend -1.6 (-2.7, -0.5)
Alaska 6 99.3 (95.2, 103.5) 40 (31, 48) 449 stable stable trend 0.3 (-0.2, 0.8)
Vermont 6 115.2 (110.2, 120.4) 5 (2, 22) 403 stable stable trend 0.1 (-0.4, 0.5)
Wyoming 6 99.4 (94.7, 104.3) 41 (27, 49) 336 stable stable trend 0.3 (-0.4, 1.0)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/18/2024 10:17 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top